The effect of hepatitis B virus status of the donor on the hepatitis B virus serology of the recipient after allogeneic hematopoietic cell transplantation

被引：0
|
作者：
Idilman, R
Soydan, E
Arat, M
Toruner, M
Soykan, I
Karayalcin, S
Ustun, C
Topcuoglu, P
Ozcan, M
Arslan, O
Beksac, M
Ilhan, O
Akan, H
Ozden, A
机构：
[1] Ankara Univ, Sch Med, Dept Gastroenterol, TR-06100 Ankara, Turkey
[2] Ankara Univ, Sch Med, Dept Hematol, TR-06100 Ankara, Turkey
来源：
JOURNAL OF HEPATOLOGY | 2003年 / 38卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
502
引用
收藏
页码：146 / 146
页数：1
相关论文
共 50 条
  • [21] The effect of hepatitis B replication status on hepatitis B immunoglobulin dose requirements and pharmacokinetics in liver transplantation for hepatitis B virus
    Dickson, RC
    Terrault, N
    Ishitani, M
    Reddy, R
    Sheiner, P
    Soldevila-Pico, C
    Luketic, V
    Brundage, R
    Jensen, D
    Fried, M
    Brown, RS
    Muenz, L
    Horwith, G
    Lok, A
    HEPATOLOGY, 2004, 40 (04) : 190A - 190A
  • [22] Transfer of hepatitis B immunity by allogeneic hematopoietic cell transplantation and donor lymphocyte infusion
    Lindemann, M
    Barsegian, V
    Fiedler, M
    Beelen, DW
    Roggendorf, M
    Grosse-Wilde, H
    GENES AND IMMUNITY, 2003, 4 : S52 - S52
  • [23] Hepatitis B Virus and Hepatitis D Virus Recurrence in Patients Undergoing Liver Transplantation for Hepatitis B Virus and Hepatitis B Virus Plus Hepatitis D Virus
    Adil, B.
    Fatih, O.
    Volkan, I.
    Bora, B.
    Veysel, E.
    Koray, K.
    Cemalettin, K.
    Burak, I.
    Sezai, Y.
    TRANSPLANTATION PROCEEDINGS, 2016, 48 (06) : 2119 - 2123
  • [24] Prevalence, incidence and clinical outcome of hepatitis B virus and hepatitis C virus hepatitis in patients undergoing allogeneic hematopoietic stem cell transplantation between 2001 and 2004
    Francisci, Daniela
    Aversa, Franco
    Coricelli, Vittoria
    Carotti, Alessandra
    Canovari, Benedetta
    Falcinelli, Flavio
    Belfiori, Barbara
    Aloisi, Teresa
    Baldelli, Franco
    Martelli, Massimo Fabrizio
    Stagni, Giuliano
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2006, 91 (07): : 980 - 982
  • [25] Evaluation and management of hepatitis B virus infection in hematopoietic stem cell transplantation: before and after transplantation
    Idilman, Ramazan
    Arat, Matlu
    EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2011, 9 (08) : 641 - 652
  • [26] Reactivation of resolved hepatitis B virus infection after allogeneic haematopoietic stem cell transplantation
    Knöll, A
    Boehm, S
    Hahn, J
    Holler, E
    Jilg, W
    BONE MARROW TRANSPLANTATION, 2004, 33 (09) : 925 - 929
  • [27] Reactivation of resolved hepatitis B virus infection after allogeneic haematopoietic stem cell transplantation
    A Knöll
    S Boehm
    J Hahn
    E Holler
    W Jilg
    Bone Marrow Transplantation, 2004, 33 : 925 - 929
  • [28] Efficacy and tolerability of Entecavir for hepatitis B virus infection after hematopoietic stem cell transplantation
    Aoki, Jun
    Kimura, Kiminori
    Kakihana, Kazuhiko
    Ohashi, Kazuteru
    Sakamaki, Hisashi
    SPRINGERPLUS, 2014, 3
  • [29] Influence of Donor or Recipient Hepatitis B Virus Infection on Long-Term Outcomes after Kidney Transplantation
    Yuan, Qing
    Hong, Shanjuan
    Ortiz, Andric
    Elias, Nahel
    JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2020, 231 (04) : S300 - S301
  • [30] Influence of donor and recipient hepatitis B virus infection on long-term outcomes after kidney transplantation
    Yuan, Qing
    Haque, Omar
    Hong, Shanjuan
    Ortiz, Andric
    Bethea, Emily D.
    Sise, Meghan E.
    Markmann, James F.
    Elias, Nahel
    CLINICAL TRANSPLANTATION, 2021, 35 (12)
12345